A three-antigen Plasmodium falciparum DNA prime—Adenovirus boost malaria vaccine regimen is superior to a two-antigen regimen and protects against controlled human malaria infection in healthy malaria-naïve adults (PLoS One, 2021)

(untitled) - Sklar, MJ; Maiolatesi, S; Patterson, N; Berrie, E; Bellamy, D; Bittaye, M; Ewer, K; Lawrie, A; Hill, A